Filing metadata

Accession number
0001209191-23-005791
Form type
Form 4
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
Jan 31, 2023
Reporting period
Jan 27, 2023
Description
Insider transaction

Explore SEC Filings Hub